TM
ThirdLaw Molecular, Inc.
SEC filingBiotechnology · Blue Bell, PA
Amount raised$5.5Msold at filing
Total offering$5.5M
Investors in the raise4count reported to the SEC
FiledOct 8, 2025first sale Sep 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christian SchafmeisterExecutive Officer, Director
David ScheerDirector
Brian HalakDirector
Eric HeilExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.